MR Lymphography with Subcutaneous Administration of HAS-Gd-DTPA: an Initial Study in Rabbits

WU Yuan-kui,XU Yi-kai,LIU Guo-qing,JIA Ming,LIAO Xin,CHEN Wei-guo
DOI: https://doi.org/10.3321/j.issn:1003-3289.2007.02.009
2007-01-01
Abstract:Objective To investigate preliminarily the normal appearances of MR lymphography with subcutaneous administration of HSA-Gd-DTPA and the signal intensity time course. Methods Ten healthy New-Zeanland rabbits weighted at 2.0-2.5 kg were enrolled in this study. The rabbits were in the supine position when the popliteal lymph nodes were scanned in the axial and sagittal planes. T1-weighted (TR/TE=539/14 ms), T1-weighted fat suppressed (TR/TE=539/14 ms), and T2-weighted (TR/TE=2234/85 ms) spin-echo (SE) images of the lymph nodes were obtained before contrast agent administration, and T1WI images were obtained 3 h, 6 h, 12 h, 24 h and 48 h after subcutaneous injection of 0.5 ml 0.20 mmol Gd/L HSA-Gd-DTPA into the interdigital skin folds of bilateral hind limb respectively. Post-contrast MR images were obtained in the same imaging planes as pre-contrast images with identical scan parameters. The signal intensities of popliteal lymph node were measured on unenhanced images and enhanced ones, and the enhancing rates(E%) were calculated to draw the signal-time course curve. Results On unenhanced images, the lymph node appeared to be iso-intensity or slight hyper-intensity on T1WI (or T1WI FS) and hyper-intensity on T2WI. On enhanced images, the lymph nodes and lymphatic vessels showed remarkable homogeneous enhancement. The E% was 40.7% and 42.8% at the 3rd hours, 75.6% and 79.7% at the 6th hours on the T1WI and T1WI FS images respectively. The peak enhancement occurred at the 24th hours with the enhancing rate of 215.4% and 232.4% on T1WI and T1WI FS respectively. The enhancement effect was still remarkable at the 48th hours with the E% closed to 100%. Conclusion MR lymphography could display both lymph nodes and lymphatic vessels clearly during the 12-48 h period after subcutaneous injection of HSA-Gd-DTPA at the dose of 0.1 mmol HSA-Gd-DTPA per limb, and the technique might be applied in the imaging evaluation of lymphatic diseases.
What problem does this paper attempt to address?